Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 13/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | SDCBP | O00560 | 2/20 | 0.32 |
| ▸ | SDC2 | P34741 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29121206 | 1.00 | EPHX1 (0.36) | EPHX1FFAR4S1PR1SLC6A2SLC6A4 | |
| SCHEMBL29121324 | 0.90 | FFAR4 (0.35) | EPHX1FFAR4S1PR1SLC6A2SLC6A4 | |
| SCHEMBL29228166 | 0.90 | FFAR4 (0.35) | EPHX1FFAR4S1PR1SLC6A2SLC6A4 | |
| SCHEMBL29121158 | 0.89 | PLA2G10 (0.33) | FFAR4 | |
| SCHEMBL28828659 | 0.89 | PLA2G10 (0.33) | FFAR4 | |
| SCHEMBL28828633 | 0.89 | SLC6A2 (0.34) | FFAR4S1PR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL29121290 | 0.89 | SLC6A2 (0.34) | FFAR4S1PR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL29121155 | 0.87 | FFAR4 (0.36) | FFAR4S1PR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL29121237 | 0.87 | APP (0.37) | FFAR4SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28828612 | 0.87 | APP (0.37) | FFAR4SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114829361-B | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same | 柳韩洋行 | 2024-07-16 | — | — | CN | claimed |
| CN-114829361-A | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same | 柳韩洋行 | 2022-07-29 | — | — | CN | claimed |
| CN-114829361-B | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same | 柳韩洋行 | 2024-07-16 | — | — | CN | disclosed |
| CN-114829361-A | Derivatives having 2, 3-dihydro-1H-indene or 2, 3-dihydrobenzofuran moiety or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing same | 柳韩洋行 | 2022-07-29 | — | — | CN | disclosed |